Wednesday, September 27, 2023

Besins Healthcare announces launch of Utrogestan 100mg Body Identical, Micronised Progesterone

Besins Healthcare is proud to announce a further commitment to Menopause Hormone Health in Ireland, with the launch of Utrogestan 100mg Body Identical, Micronised Progesterone.

Besins Healthcare is a global pharmaceutical company and world leader in novel body identical therapies for menopause, gynaecological, fertility and obstetric conditions as well as androgen deficiency in men.

Now announcing the launch of Utrogestan® 100mg oral capsules to the Irish market, the only micronised, body Identical progesterone licenced in Ireland for Hormone Replacement Therapy (HRT) in post-menopausal women with an intact uterus.1

Utrogestan is indicated for adjunctive use with oestrogen in post-menopausal women with an intact uterus as hormone replacement therapy (HRT).2

Progesterone greatly reduces the oestrogen-induced risk of endometrial cancer in women with an intact uterus during HRT treatment.2 The availability of Utrogestan® 100mg capsules enables physicians to individualise their patient’s HRT treatment in accordance with NICE guidelines, choosing between two different dosing regimens.2,3

Besins Healthcare look forward to continuing their support of healthcare professionals in the care of their patient’s hormone health.

Patient leaflets for or additional information on Utrogestan 100mg are available by contacting Besins Healthcare at 01 463 7473. Please refer to the SmPC for further information.


  1. MIMS Ireland: Prescribing Guide for Healthcare Professionals, last accessed August 2023.
  2. Utrogestan 100mg Capsules, SPC, last accessed August 2023.
  3. NICE Guidelines Menopause: diagnosis and management ( last accessed August 2023.

Source link

Related Articles

Leave a Reply

Stay Connected

- Advertisement -spot_img

Latest Articles

%d bloggers like this: